Home Industries Market Insights About Us Publisher Contact us

Global Pharmacovigilance (PV) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

ReportID: 283160

|

Published Date: 22/7/2020

|

No. of Pages: 130

|

Categories: Life Sciences

|

Formate :

The Pharmacovigilance (PV) market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Pharmacovigilance (PV) market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Pharmacovigilance (PV) market. The report focuses on well-known providers in the global Pharmacovigilance (PV) industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Pharmacovigilance (PV) Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Pharmacovigilance (PV) market covered in Chapter 4:
PAREXEL International Corporation
Capgemini
Wipro Limited
TAKE Solutions Ltd
Foresight Group International AG
IBM
BioClinica
Cognizant
Accenture
Laboratory Corporation of America Holdings
IT Clinical
ICON PLC
ArisGlobal
United BioSource Corporation

In Chapter 11 and 13.3, on the basis of types, the Pharmacovigilance (PV) market from 2015 to 2026 is primarily split into:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

In Chapter 12 and 13.4, on the basis of applications, the Pharmacovigilance (PV) market from 2015 to 2026 covers:
Hospitals
Pharmaceutical Companies
Other End Users

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Pharmacovigilance (PV) Market Share by Type (2020-2026)
1.5.2 Spontaneous Reporting
1.5.3 Intensified ADR Reporting
1.5.4 Targeted Spontaneous Reporting
1.5.5 Cohort Event Monitoring
1.5.6 EHR Mining
1.6 Market by Application
1.6.1 Global Pharmacovigilance (PV) Market Share by Application (2020-2026)
1.6.2 Hospitals
1.6.3 Pharmaceutical Companies
1.6.4 Other End Users
1.7 Pharmacovigilance (PV) Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Pharmacovigilance (PV) Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Pharmacovigilance (PV) Market
3.1 Value Chain Status
3.2 Pharmacovigilance (PV) Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Pharmacovigilance (PV)
3.2.3 Labor Cost of Pharmacovigilance (PV)
3.2.3.1 Labor Cost of Pharmacovigilance (PV) Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 PAREXEL International Corporation
4.1.1 PAREXEL International Corporation Basic Information
4.1.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.1.3 PAREXEL International Corporation Pharmacovigilance (PV) Market Performance (2015-2020)
4.1.4 PAREXEL International Corporation Business Overview
4.2 Capgemini
4.2.1 Capgemini Basic Information
4.2.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.2.3 Capgemini Pharmacovigilance (PV) Market Performance (2015-2020)
4.2.4 Capgemini Business Overview
4.3 Wipro Limited
4.3.1 Wipro Limited Basic Information
4.3.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.3.3 Wipro Limited Pharmacovigilance (PV) Market Performance (2015-2020)
4.3.4 Wipro Limited Business Overview
4.4 TAKE Solutions Ltd
4.4.1 TAKE Solutions Ltd Basic Information
4.4.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.4.3 TAKE Solutions Ltd Pharmacovigilance (PV) Market Performance (2015-2020)
4.4.4 TAKE Solutions Ltd Business Overview
4.5 Foresight Group International AG
4.5.1 Foresight Group International AG Basic Information
4.5.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.5.3 Foresight Group International AG Pharmacovigilance (PV) Market Performance (2015-2020)
4.5.4 Foresight Group International AG Business Overview
4.6 IBM
4.6.1 IBM Basic Information
4.6.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.6.3 IBM Pharmacovigilance (PV) Market Performance (2015-2020)
4.6.4 IBM Business Overview
4.7 BioClinica
4.7.1 BioClinica Basic Information
4.7.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.7.3 BioClinica Pharmacovigilance (PV) Market Performance (2015-2020)
4.7.4 BioClinica Business Overview
4.8 Cognizant
4.8.1 Cognizant Basic Information
4.8.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.8.3 Cognizant Pharmacovigilance (PV) Market Performance (2015-2020)
4.8.4 Cognizant Business Overview
4.9 Accenture
4.9.1 Accenture Basic Information
4.9.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.9.3 Accenture Pharmacovigilance (PV) Market Performance (2015-2020)
4.9.4 Accenture Business Overview
4.10 Laboratory Corporation of America Holdings
4.10.1 Laboratory Corporation of America Holdings Basic Information
4.10.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.10.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Market Performance (2015-2020)
4.10.4 Laboratory Corporation of America Holdings Business Overview
4.11 IT Clinical
4.11.1 IT Clinical Basic Information
4.11.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.11.3 IT Clinical Pharmacovigilance (PV) Market Performance (2015-2020)
4.11.4 IT Clinical Business Overview
4.12 ICON PLC
4.12.1 ICON PLC Basic Information
4.12.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.12.3 ICON PLC Pharmacovigilance (PV) Market Performance (2015-2020)
4.12.4 ICON PLC Business Overview
4.13 ArisGlobal
4.13.1 ArisGlobal Basic Information
4.13.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.13.3 ArisGlobal Pharmacovigilance (PV) Market Performance (2015-2020)
4.13.4 ArisGlobal Business Overview
4.14 United BioSource Corporation
4.14.1 United BioSource Corporation Basic Information
4.14.2 Pharmacovigilance (PV) Product Profiles, Application and Specification
4.14.3 United BioSource Corporation Pharmacovigilance (PV) Market Performance (2015-2020)
4.14.4 United BioSource Corporation Business Overview

5 Global Pharmacovigilance (PV) Market Analysis by Regions
5.1 Global Pharmacovigilance (PV) Sales, Revenue and Market Share by Regions
5.1.1 Global Pharmacovigilance (PV) Sales by Regions (2015-2020)
5.1.2 Global Pharmacovigilance (PV) Revenue by Regions (2015-2020)
5.2 North America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
5.3 Europe Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
5.6 South America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

6 North America Pharmacovigilance (PV) Market Analysis by Countries
6.1 North America Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries
6.1.1 North America Pharmacovigilance (PV) Sales by Countries (2015-2020)
6.1.2 North America Pharmacovigilance (PV) Revenue by Countries (2015-2020)
6.1.3 North America Pharmacovigilance (PV) Market Under COVID-19
6.2 United States Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
6.2.1 United States Pharmacovigilance (PV) Market Under COVID-19
6.3 Canada Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
6.4 Mexico Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

7 Europe Pharmacovigilance (PV) Market Analysis by Countries
7.1 Europe Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries
7.1.1 Europe Pharmacovigilance (PV) Sales by Countries (2015-2020)
7.1.2 Europe Pharmacovigilance (PV) Revenue by Countries (2015-2020)
7.1.3 Europe Pharmacovigilance (PV) Market Under COVID-19
7.2 Germany Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.2.1 Germany Pharmacovigilance (PV) Market Under COVID-19
7.3 UK Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.3.1 UK Pharmacovigilance (PV) Market Under COVID-19
7.4 France Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.4.1 France Pharmacovigilance (PV) Market Under COVID-19
7.5 Italy Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.5.1 Italy Pharmacovigilance (PV) Market Under COVID-19
7.6 Spain Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.6.1 Spain Pharmacovigilance (PV) Market Under COVID-19
7.7 Russia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
7.7.1 Russia Pharmacovigilance (PV) Market Under COVID-19

8 Asia-Pacific Pharmacovigilance (PV) Market Analysis by Countries
8.1 Asia-Pacific Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Pharmacovigilance (PV) Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Pharmacovigilance (PV) Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Pharmacovigilance (PV) Market Under COVID-19
8.2 China Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.2.1 China Pharmacovigilance (PV) Market Under COVID-19
8.3 Japan Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.3.1 Japan Pharmacovigilance (PV) Market Under COVID-19
8.4 South Korea Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.4.1 South Korea Pharmacovigilance (PV) Market Under COVID-19
8.5 Australia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.6 India Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.6.1 India Pharmacovigilance (PV) Market Under COVID-19
8.7 Southeast Asia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Pharmacovigilance (PV) Market Under COVID-19

9 Middle East and Africa Pharmacovigilance (PV) Market Analysis by Countries
9.1 Middle East and Africa Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pharmacovigilance (PV) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Pharmacovigilance (PV) Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Pharmacovigilance (PV) Market Under COVID-19
9.2 Saudi Arabia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
9.3 UAE Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
9.4 Egypt Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
9.5 Nigeria Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
9.6 South Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

10 South America Pharmacovigilance (PV) Market Analysis by Countries
10.1 South America Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries
10.1.1 South America Pharmacovigilance (PV) Sales by Countries (2015-2020)
10.1.2 South America Pharmacovigilance (PV) Revenue by Countries (2015-2020)
10.1.3 South America Pharmacovigilance (PV) Market Under COVID-19
10.2 Brazil Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
10.2.1 Brazil Pharmacovigilance (PV) Market Under COVID-19
10.3 Argentina Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
10.4 Columbia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
10.5 Chile Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

11 Global Pharmacovigilance (PV) Market Segment by Types
11.1 Global Pharmacovigilance (PV) Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Pharmacovigilance (PV) Sales and Market Share by Types (2015-2020)
11.1.2 Global Pharmacovigilance (PV) Revenue and Market Share by Types (2015-2020)
11.2 Spontaneous Reporting Sales and Price (2015-2020)
11.3 Intensified ADR Reporting Sales and Price (2015-2020)
11.4 Targeted Spontaneous Reporting Sales and Price (2015-2020)
11.5 Cohort Event Monitoring Sales and Price (2015-2020)
11.6 EHR Mining Sales and Price (2015-2020)

12 Global Pharmacovigilance (PV) Market Segment by Applications
12.1 Global Pharmacovigilance (PV) Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Pharmacovigilance (PV) Sales and Market Share by Applications (2015-2020)
12.1.2 Global Pharmacovigilance (PV) Revenue and Market Share by Applications (2015-2020)
12.2 Hospitals Sales, Revenue and Growth Rate (2015-2020)
12.3 Pharmaceutical Companies Sales, Revenue and Growth Rate (2015-2020)
12.4 Other End Users Sales, Revenue and Growth Rate (2015-2020)

13 Pharmacovigilance (PV) Market Forecast by Regions (2020-2026)
13.1 Global Pharmacovigilance (PV) Sales, Revenue and Growth Rate (2020-2026)
13.2 Pharmacovigilance (PV) Market Forecast by Regions (2020-2026)
13.2.1 North America Pharmacovigilance (PV) Market Forecast (2020-2026)
13.2.2 Europe Pharmacovigilance (PV) Market Forecast (2020-2026)
13.2.3 Asia-Pacific Pharmacovigilance (PV) Market Forecast (2020-2026)
13.2.4 Middle East and Africa Pharmacovigilance (PV) Market Forecast (2020-2026)
13.2.5 South America Pharmacovigilance (PV) Market Forecast (2020-2026)
13.3 Pharmacovigilance (PV) Market Forecast by Types (2020-2026)
13.4 Pharmacovigilance (PV) Market Forecast by Applications (2020-2026)
13.5 Pharmacovigilance (PV) Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source

List of Tables and Figures
Table Global Pharmacovigilance (PV) Market Size Growth Rate by Type (2020-2026)
Figure Global Pharmacovigilance (PV) Market Share by Type in 2019 & 2026
Figure Spontaneous Reporting Features
Figure Intensified ADR Reporting Features
Figure Targeted Spontaneous Reporting Features
Figure Cohort Event Monitoring Features
Figure EHR Mining Features
Table Global Pharmacovigilance (PV) Market Size Growth by Application (2020-2026)
Figure Global Pharmacovigilance (PV) Market Share by Application in 2019 & 2026
Figure Hospitals Description
Figure Pharmaceutical Companies Description
Figure Other End Users Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Pharmacovigilance (PV) Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Pharmacovigilance (PV) Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of Pharmacovigilance (PV)
Figure Production Process of Pharmacovigilance (PV)
Figure Manufacturing Cost Structure of Pharmacovigilance (PV)
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table PAREXEL International Corporation Profile
Table PAREXEL International Corporation Production, Value, Price, Gross Margin 2015-2020
Table Capgemini Profile
Table Capgemini Production, Value, Price, Gross Margin 2015-2020
Table Wipro Limited Profile
Table Wipro Limited Production, Value, Price, Gross Margin 2015-2020
Table TAKE Solutions Ltd Profile
Table TAKE Solutions Ltd Production, Value, Price, Gross Margin 2015-2020
Table Foresight Group International AG Profile
Table Foresight Group International AG Production, Value, Price, Gross Margin 2015-2020
Table IBM Profile
Table IBM Production, Value, Price, Gross Margin 2015-2020
Table BioClinica Profile
Table BioClinica Production, Value, Price, Gross Margin 2015-2020
Table Cognizant Profile
Table Cognizant Production, Value, Price, Gross Margin 2015-2020
Table Accenture Profile
Table Accenture Production, Value, Price, Gross Margin 2015-2020
Table Laboratory Corporation of America Holdings Profile
Table Laboratory Corporation of America Holdings Production, Value, Price, Gross Margin 2015-2020
Table IT Clinical Profile
Table IT Clinical Production, Value, Price, Gross Margin 2015-2020
Table ICON PLC Profile
Table ICON PLC Production, Value, Price, Gross Margin 2015-2020
Table ArisGlobal Profile
Table ArisGlobal Production, Value, Price, Gross Margin 2015-2020
Table United BioSource Corporation Profile
Table United BioSource Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Global Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Global Pharmacovigilance (PV) Revenue ($) and Growth (2015-2020)
Table Global Pharmacovigilance (PV) Sales by Regions (2015-2020)
Table Global Pharmacovigilance (PV) Sales Market Share by Regions (2015-2020)
Table Global Pharmacovigilance (PV) Revenue ($) by Regions (2015-2020)
Table Global Pharmacovigilance (PV) Revenue Market Share by Regions (2015-2020)
Table Global Pharmacovigilance (PV) Revenue Market Share by Regions in 2015
Table Global Pharmacovigilance (PV) Revenue Market Share by Regions in 2019
Figure North America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Europe Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure South America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure North America Pharmacovigilance (PV) Revenue ($) and Growth (2015-2020)
Table North America Pharmacovigilance (PV) Sales by Countries (2015-2020)
Table North America Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
Figure North America Pharmacovigilance (PV) Sales Market Share by Countries in 2015
Figure North America Pharmacovigilance (PV) Sales Market Share by Countries in 2019
Table North America Pharmacovigilance (PV) Revenue ($) by Countries (2015-2020)
Table North America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Figure North America Pharmacovigilance (PV) Revenue Market Share by Countries in 2015
Figure North America Pharmacovigilance (PV) Revenue Market Share by Countries in 2019
Figure United States Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Canada Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Mexico Pharmacovigilance (PV) Sales and Growth (2015-2020)
Figure Europe Pharmacovigilance (PV) Revenue ($) Growth (2015-2020)
Table Europe Pharmacovigilance (PV) Sales by Countries (2015-2020)
Table Europe Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
Figure Europe Pharmacovigilance (PV) Sales Market Share by Countries in 2015
Figure Europe Pharmacovigilance (PV) Sales Market Share by Countries in 2019
Table Europe Pharmacovigilance (PV) Revenue ($) by Countries (2015-2020)
Table Europe Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Figure Europe Pharmacovigilance (PV) Revenue Market Share by Countries in 2015
Figure Europe Pharmacovigilance (PV) Revenue Market Share by Countries in 2019
Figure Germany Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure UK Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure France Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Italy Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Spain Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Russia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Pharmacovigilance (PV) Revenue ($) and Growth (2015-2020)
Table Asia-Pacific Pharmacovigilance (PV) Sales by Countries (2015-2020)
Table Asia-Pacific Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Pharmacovigilance (PV) Sales Market Share by Countries in 2015
Figure Asia-Pacific Pharmacovigilance (PV) Sales Market Share by Countries in 2019
Table Asia-Pacific Pharmacovigilance (PV) Revenue ($) by Countries (2015-2020)
Table Asia-Pacific Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Pharmacovigilance (PV) Revenue Market Share by Countries in 2015
Figure Asia-Pacific Pharmacovigilance (PV) Revenue Market Share by Countries in 2019
Figure China Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Japan Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure South Korea Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Australia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure India Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Southeast Asia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Pharmacovigilance (PV) Revenue ($) and Growth (2015-2020)
Table Middle East and Africa Pharmacovigilance (PV) Sales by Countries (2015-2020)
Table Middle East and Africa Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Pharmacovigilance (PV) Revenue ($) by Countries (2015-2020)
Table Middle East and Africa Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Pharmacovigilance (PV) Revenue Market Share by Countries in 2015
Figure Middle East and Africa Pharmacovigilance (PV) Revenue Market Share by Countries in 2019
Figure Saudi Arabia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure UAE Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Egypt Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Nigeria Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure South Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure South America Pharmacovigilance (PV) Revenue ($) and Growth (2015-2020)
Table South America Pharmacovigilance (PV) Sales by Countries (2015-2020)
Table South America Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
Table South America Pharmacovigilance (PV) Revenue ($) by Countries (2015-2020)
Table South America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Figure South America Pharmacovigilance (PV) Revenue Market Share by Countries in 2015
Figure South America Pharmacovigilance (PV) Revenue Market Share by Countries in 2019
Figure Brazil Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Argentina Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Columbia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Figure Chile Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
Table Global Pharmacovigilance (PV) Sales by Types (2015-2020)
Table Global Pharmacovigilance (PV) Sales Share by Types (2015-2020)
Table Global Pharmacovigilance (PV) Revenue ($) by Types (2015-2020)
Table Global Pharmacovigilance (PV) Revenue Share by Types (2015-2020)
Figure Global Spontaneous Reporting Sales and Growth Rate (2015-2020)
Figure Global Spontaneous Reporting Price (2015-2020)
Figure Global Intensified ADR Reporting Sales and Growth Rate (2015-2020)
Figure Global Intensified ADR Reporting Price (2015-2020)
Figure Global Targeted Spontaneous Reporting Sales and Growth Rate (2015-2020)
Figure Global Targeted Spontaneous Reporting Price (2015-2020)
Figure Global Cohort Event Monitoring Sales and Growth Rate (2015-2020)
Figure Global Cohort Event Monitoring Price (2015-2020)
Figure Global EHR Mining Sales and Growth Rate (2015-2020)
Figure Global EHR Mining Price (2015-2020)
Table Global Pharmacovigilance (PV) Sales by Applications (2015-2020)
Table Global Pharmacovigilance (PV) Sales Share by Applications (2015-2020)
Figure Global Hospitals Sales and Growth Rate (2015-2020)
Figure Global Hospitals Revenue and Growth Rate (2015-2020)
Figure Global Pharmaceutical Companies Sales and Growth Rate (2015-2020)
Figure Global Pharmaceutical Companies Revenue and Growth Rate (2015-2020)
Figure Global Other End Users Sales and Growth Rate (2015-2020)
Figure Global Other End Users Revenue and Growth Rate (2015-2020)
Figure Global Pharmacovigilance (PV) Sales and Growth Rate (2020-2026)
Figure Global Pharmacovigilance (PV) Revenue ($) and Growth Rate (2020-2026)
Table Global Pharmacovigilance (PV) Sales Forecast by Regions (2020-2026)
Table Global Pharmacovigilance (PV) Revenue Forecast by Regions (2020-2026)
Figure North America Pharmacovigilance (PV) Sales Forecast (2020-2026)
Figure North America Pharmacovigilance (PV) Revenue Forecast (2020-2026)
Figure Europe Pharmacovigilance (PV) Sales Forecast (2020-2026)
Figure Europe Pharmacovigilance (PV) Revenue Forecast (2020-2026)
Figure Asia-Pacific Pharmacovigilance (PV) Sales Forecast (2020-2026)
Figure Asia-Pacific Pharmacovigilance (PV) Revenue Forecast (2020-2026)
Figure Middle East and Africa Pharmacovigilance (PV) Sales Forecast (2020-2026)
Figure Middle East and Africa Pharmacovigilance (PV) Revenue Forecast (2020-2026)
Figure South America Pharmacovigilance (PV) Sales Forecast (2020-2026)
Figure South America Pharmacovigilance (PV) Revenue Forecast (2020-2026)
Table Global Pharmacovigilance (PV) Sales Forecast by Types (2020-2026)
Table Global Pharmacovigilance (PV) Sales Market Share Forecast by Types (2020-2026)
Table Global Pharmacovigilance (PV) Revenue Forecast by Types (2020-2026)
Table Global Pharmacovigilance (PV) Revenue Market Share Forecast by Types (2020-2026)
Table Global Pharmacovigilance (PV) Sales Forecast by Applications (2020-2026)
Table Global Pharmacovigilance (PV) Sales Market Share Forecast by Applications (2020-2026)
Table Global Pharmacovigilance (PV) Revenue Forecast by Applications (2020-2026)
Table Global Pharmacovigilance (PV) Revenue Market Share Forecast by Applications (2020-2026)

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$3400

Multi User

US$5100

Corporate User

US$5100

Excel Datapack

US$2000

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

Global Pharmacovigilance (PV) Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)